EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
批准号:
10330633
负责人:
SERGIO E BARANZINI
金额:
$43.73万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-24 至 2022-01-23
关键词:
AgreementArbitrationBudgetsCohort StudiesCommunicationConflict (Psychology)DataData SetEnsureGoalsInstitutionIntellectual PropertyJointsKnowledgeMedicalMultiomic DataNatureOffice of Administrative ManagementOutcomePersonsPhasePilot ProjectsPlayPrincipal InvestigatorPublicationsResearchResourcesRoleSystemTechnology TransferTestingWorkbasecohortcomputerized toolsdesignknowledge graphmembermultiple omicsnovelproduct developmentprograms
中文摘要
1. 作为多pi (MPI)团队共同努力的基本原理。该试点项目的核心是
英文摘要
1. Rationale for the joint effort as a multi-PI (MPI) team. At the core of the is pilot project is the
combination of two sets of resources and expertise that each of the two principal investigators
(PIs), Dr. Sergio Baranzini (UCSF) and Dr. Sui Huang (ISB) will contribute to develop, test and
deliver a computational tool (“Automatic Relay Agent”, ARA) as defined by the FOA of Biomedical
Translator program of NCATS as a milestone for the “First Segment” (January- March, 2020). The
ARA envisioned by this team is EVIDARA, a system that extracts knowledge from a knowledge
graph (KG) and evaluates it against multi-omics raw data of a large cohort for evidential support.
The evidenced-tested knowledge is then relaying it to the Biomedical Translator. The two
resources that will be combined to build EVIDARA are: (i) A novel knowledge graph, SPOKE and
(ii) a new genre of multi-omics data sets from scientific wellness studies. The two PIs will bring
these two resources and thus play complementary role: Dr. Sergio Baranzini, with his team at
UCSF, is the developer of SPOKE and Dr. Sui Huang provides subject matter expertise in multiomics
studies and has access to data from a cohort studied at ISB that he has been analyzing.
Dr. Baranzini will bring expertise in all computational aspects of SPOKE and its new applications
and Dr. Huang will also act as subject matter expert in multi-omics driven medical practice and
research to guide product development and testing.
2. Goal of project and continuation. The pilot project id defined by the common goal of
delivering the milestone product, EVIDARA as described in the proposal. If the pilot project is
successful and this team is selected to continue to the “Second Segment” (an up to five project)
the two PIs will work again as an MPI team and jointly design the expansion of the project into
this second phase and jointly prepare the new research plan to NCATS.
3. Management and coordination. Dr. Huang, is the contact-MPI and will coordinate the project
and directly communicate with Dr. Baranzini to ensure that both MPIs are kept informed about
the project’s technical progress and all administrative matters. Each MPI will assume fiscal and
administrative management of their own team, as reflected in the budget and consortium
subcontract. Dr. Huang will be responsible for communication with NCATS Program manager
team. The two MPIs and their team members and institutional collaborators agree to work jointly
as a group towards the milestone product. Should publications result, both will be co-senior
authors and their team members included as authors based on their contribution, following
common academic practice. If there are any conflicts in the course of the project, both PIs and
collaborators will meet in person and work in a spirit of cooperation to resolve any conflicts. Given
that Drs. Huang and Baranzini have interacted academically for almost two decades, share the
same scholarly perspective and the complementary and synergistic nature of their expertise that
is required for the project it is highly unlikely a neutral arbitration committee would be required to
resolve conflicts.
4. Intellectual Property. For intellectual property issue, the Technology Transfer Offices at each
of the PI’s institutions will be responsible for agreements relating to the research and the outcome
of the work.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
-
批准号:10547256
-
项目类别:
-
资助金额:$53.29万
-
财政年份:2020
-
负责人:SERGIO E BARANZINI
-
依托单位:
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
-
批准号:10706762
-
项目类别:
-
资助金额:$53.29万
-
财政年份:2020
-
负责人:SERGIO E BARANZINI
-
依托单位:
EVIDARA: Automated Evidential Support from Raw Data for relay agents in Biomedical KG Queries
-
批准号:10057190
-
项目类别:
-
资助金额:$89.6万
-
财政年份:2020
-
负责人:SERGIO E BARANZINI
-
依托单位:
The genetic basis of progression in multiple sclerosis
-
批准号:10084323
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2017
-
负责人:SERGIO E BARANZINI
-
依托单位:
The genetic basis of progression in multiple sclerosis
-
批准号:9737736
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2017
-
负责人:SERGIO E BARANZINI
-
依托单位:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
-
批准号:8925166
-
项目类别:
-
资助金额:$51.13万
-
财政年份:2014
-
负责人:SERGIO E BARANZINI
-
依托单位:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
-
批准号:9116321
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2014
-
负责人:SERGIO E BARANZINI
-
依托单位:
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
-
批准号:9330939
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2014
-
负责人:SERGIO E BARANZINI
-
依托单位:
EXTENSIVE SEARCH FOR AN X-LINKED ACC GENE
-
批准号:2418226
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1998
-
负责人:SERGIO E BARANZINI
-
依托单位:
海外基金